Emma Fixsen, MD

Article

Atypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung Adenocarcinoma

Author:

Emma Fixsen, MD

Jigar Patel, MD

Meenal Kheterpal, MD

Immune checkpoint inhibitors such as nivolumab, a programmed cell death protein 1 (PD-1) inhibitor, are associated with immune-related adverse...

• Read More